Elizabeth Anne Ramsburg

Title: Elizabeth Anne Ramsburg: Innovator in Neurodegenerative Disease Research

Introduction

Elizabeth Anne Ramsburg is a prominent inventor based in Chalfont, PA (US). She has made significant contributions to the field of neurodegenerative diseases, particularly through her innovative research and patented methods. With a total of 5 patents, her work focuses on advancing treatments for conditions such as Alzheimer's Disease.

Latest Patents

Ramsburg's latest patents include a method for the safe administration of a phosphorylated Tau peptide vaccine. This method describes how to induce anti-phosphorylated Tau antibodies without causing severe adverse events in humans. The approach involves administering an effective amount of liposomes that include a toll-like receptor 4 agonist and a Tau phosphopeptide presented on the surface of the liposome. Another notable patent details compositions of phosphorylated tau peptides and their uses. This patent describes liposomes containing tau peptides, particularly phosphorylated tau peptides, and conjugates that link tau peptides to an immunogenic carrier. These pharmaceutical compositions aim to treat or prevent neurodegenerative diseases, including Alzheimer's Disease.

Career Highlights

Throughout her career, Ramsburg has worked with notable companies such as Ac Immune SA and Janssen Pharmaceuticals, Inc. Her experience in these organizations has allowed her to contribute to groundbreaking research and development in the pharmaceutical industry.

Collaborations

Ramsburg has collaborated with esteemed colleagues, including Donata De Marco and Charlotte Sadaka. These partnerships have further enhanced her research efforts and innovation in the field.

Conclusion

Elizabeth Anne Ramsburg is a key figure in the fight against neurodegenerative diseases, with her innovative patents paving the way for new treatment options. Her dedication to research and collaboration continues to impact the medical community positively.